Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma, Follicular × Ketorolac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 3 Pain 3 Agnosia 3 Inflammation 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lymphoma 1 Kidney Neoplasms 1 Ileus 1 Fallopian Tube Neoplasms 1 Emergencies 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Curative Breast Cancer Surgery 1 Constipation 1 Colonic Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Acute Pain 1

Interventions

Rituximab 246 Cyclophosphamide 209 fludarabine phosphate 89 Peripheral Blood Stem Cell Transplantation 89 Filgrastim 80 Etoposide 74 Radiotherapy 70 Lenalidomide 69 Vincristine 68 Prednisone 68 Doxorubicin 55 Bendamustine Hydrochloride 54 Mycophenolic Acid 53 Whole-Body Irradiation 51 Cyclosporine 50 fludarabine 46 Melphalan 45 Tacrolimus 41 Cytarabine 41 Busulfan 40 obinutuzumab 39 Methotrexate 38 Antilymphocyte Serum 34 Methylprednisolone 31 Carmustine 30 Bortezomib 29 sargramostim 27 ibritumomab tiuxetan 27 Dexamethasone 27 ibrutinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡